Gaetan Duport: A New Legislation for Medicines in Europe
Gaetan Duport, Economic and Public Health Committee (CEESP), user representative at Haute Autorité de Santé, reposted from EU Health and Food Safety on LinkedIn:
”A new step forward with the pharma package : a new legislation for medicines in Europe.
A key milestone for better access to treatement.”
Quoting EU Health and Food Safety‘s post:
”Major reform of EU pharmaceutical rules agreed!
We welcome the political agreement reached on the pharma reform last night, which is a crucial step in boosting innovation and investment in the EU’s pharma sector.
The main aim of the new rules is to make sure that medicines in the EU are safe, effective and available to all patients in Europe.
Amongst other things, the rules will:
- Expand access and availability of medicines
- Accelerate medicine supply chains – by cutting red pate for companies and reducing evaluation times for new medicines by the EMA.
- Place the EU at the forefront of pharmaceutical innovation – by offering world-leading incentives for innovative products.
- Allow for speedy market access for generic medicines
- Address medicine shortages
The new rules are complemented by the Critical Medicines’ Act proposal, the recent Life Sciences Strategy and the upcoming Biotech Act.
Check out the factsheet below for more information about the key elements of the reform
For more information.”

Stay updated with Hemostasis Today.
-
Aug 15, 2026, 19:30José Luis Neyro: E4 and DRSP Reduce Hirsutism While Showing Comparable Effects on Thrombin Generation
-
Aug 15, 2026, 19:27Mahmoud Akraym: Don’t Choose Anticoagulation as the Immediate Treatment for Unstable AF
-
Aug 15, 2026, 19:25Ahmed Bennis: DOACs Increase 1-Year Stroke Risk but Reduce MI Risk Compared With Warfarin
-
Aug 15, 2026, 19:24Megan Adediran: An Unwavering Fight for People Living With Haemophilia
-
Aug 15, 2026, 19:23Intravenous Anticoagulation Linked to Worse Early Outcomes After Noncardioembolic Stroke – International Journal of Stroke
-
Aug 15, 2026, 18:03Alejandro González Veliz: Pulmonary Embolism Is Not Always an Anticoagulation-Only Problem
-
Aug 15, 2026, 17:57Ayesha Zia: A New Foundation for Pediatric Pulmonary Embolism Research and Care
-
Aug 15, 2026, 17:50Muhammad Shaheer Bin Faheem: 25 Years of Thromboembolism and Hypertension Mortality
-
Aug 15, 2026, 17:21Bilal Salman։ NETosis as a Therapeutic Target in Inflammation and Thrombosis